| Heparanase activates the syndecan-syntenin-ALIX exosome pathway B Roucourt, S Meeussen, J Bao, P Zimmermann, G David Cell research 25 (4), 412-428, 2015 | 353 | 2015 |
| DrugComb update: a more comprehensive drug sensitivity data repository and analysis portal S Zheng, J Aldahdooh, T Shadbahr, Y Wang, D Aldahdooh, J Bao, ... Nucleic acids research 49 (W1), W174-W184, 2021 | 73 | 2021 |
| Establishment and analysis of tumor slice explants as a prerequisite for diagnostic testing AS Nagaraj, J Bao, A Hemmes, M Machado, K Närhi, EW Verschuren JoVE (Journal of Visualized Experiments), e58569, 2018 | 20 | 2018 |
| Bipartite network models to design combination therapies in acute myeloid leukaemia M Jafari, M Mirzaie, J Bao, F Barneh, S Zheng, J Eriksson, CA Heckman, ... Nature communications 13 (1), 2128, 2022 | 19 | 2022 |
| Functional diagnostics using fresh uncultured lung tumor cells to guide personalized treatments SS Talwelkar, MI Mäyränpää, L Søraas, S Potdar, J Bao, A Hemmes, ... Cell Reports Medicine 2 (8), 2021 | 8 | 2021 |
| SOX9 has distinct roles in the formation and progression of different non‐small cell lung cancer histotypes J Bao, K Närhi, A Teodòsio, A Hemmes, NM Linnavirta, MI Mäyränpää, ... The Journal of Pathology 255 (1), 16-29, 2021 | 6 | 2021 |
| Spa-RQ: an image analysis tool to visualise and quantify spatial phenotypes applied to non-small cell lung cancer J Bao, M Walliander, F Kovács, AS Nagaraj, A Hemmes, VK Sarhadi, ... Scientific Reports 9 (1), 17613, 2019 | 5 | 2019 |
| A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer M Mason, Ó Lapuente-Santana, AS Halkola, W Wang, R Mall, X Xiao, ... Journal of Translational Medicine 22 (1), 190, 2024 | 4 | 2024 |
| Facilitating the design of combination therapy in cancer using multipartite network models: Emphasis on acute myeloid leukemia M Jafari, M Mirzaie, J Bao, F Barneh, S Zheng, J Eriksson, J Tang bioRxiv, 2021.03. 18.436040, 2021 | 2 | 2021 |
| The Interplay Between HIF‐1α and EZH2 in Lung Cancer and Dual‐Targeted Drug Therapy J Wang, C Yang, H Xu, X Fan, L Jia, Y Du, S Liu, W Wang, J Zhang, ... Advanced Science 11 (7), 2303904, 2024 | 1 | 2024 |
| Patient-derived functional immuno-oncology platform identifies responders to ATR inhibitor and immunotherapy combinations in ovarian cancer AS Nagaraj, M Salko, A Sirsikar, EP Erkan, EA Pietilä, I Niemiec, J Bao, ... bioRxiv, 2024.02. 15.579904, 2024 | 1 | 2024 |
| A gene essentiality signature for studying the mechanism of action of drugs W Wang, J Bao, S Zheng, S Huang, J Aldahdooh, Y Wang, J Eriksson, ... bioRxiv, 2022.11. 07.514541, 2022 | 1 | 2022 |
| The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor Y Yang, Z Li, Y Wang, J Gao, Y Meng, S Wang, X Zhao, C Tang, W Yang, ... EMBO molecular medicine, 1-19, 2024 | | 2024 |
| Abstract PR-007: Patient-derived immunocompetent cultures reveal personalized immunotherapies and new treatment options for therapy resistant patients with high-grade serous … A Färkkilä, AS Nagaraj, EA Pietilä, M Salko, EP Erkan, I Niemiec, ... Cancer Research 84 (5_Supplement_2), PR-007-PR-007, 2024 | | 2024 |
| Patient-derived immunocompetent cultures reveal personalized immunotherapies and new treatment options for therapy resistant patients with high-grade serous ovarian cancer A Farkkila, AS Nagaraj, EA Pietila, M Salko, EP Erkan, I Niemiec, ... CANCER RESEARCH 84 (5), 2024 | | 2024 |
| Tracing back primed resistance in cancer via sister cells J Dai, S Zheng, MM Falco, J Bao, J Eriksson, S Pikkusaari, S Forstén, ... Nature Communications 15 (1), 1158, 2024 | | 2024 |
| A potential combinatorial treatment strategy to overcome olaparib resistance in high-grade ovarian cancer J Bao, EDM Ortiz, J Agudelo, R Filimonov, A Färkkilä, J Tang Cancer Research 83 (7_Supplement), 5507-5507, 2023 | | 2023 |
| Development of an adenosquamous carcinoma histopathology–selective lung metastasis model IAK Lähdeniemi, JR Devlin, AS Nagaraj, SS Talwelkar, J Bao, ... Biology open 11 (12), bio059623, 2022 | | 2022 |
| A gene essentiality signature enables predicting the mechanism of action of drugs W Wang, J Bao, S Zheng, S Huang, J Aldahdooh, Y Wang, J Eriksson, ... | | 2022 |
| Histopathology-selective spatial oncogenic phenotypes in non-small cell lung cancer J Bao Helsingin yliopisto, 2022 | | 2022 |
